Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates 
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside 
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX 
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
Pompano Beach, Fla., Dec. 07, 2015 (GLOBE NEWSWIRE) -- DS Healthcare today announced it has posted a letter to its shareholders. The letter can found by clicking here.
About DS Healthcare Group
DS Healthcare Group Inc. is a leader in the development of biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com or www.facebook.com/DS.Labs
Forward-looking statements
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov
Investor Relations DS Healthcare Group (888) 404-7770 ext. 3 [email protected]
